Christchurch Clinical Studies Trust (CCST) has joined the QuintilesIMS Prime Site program, a global network of highly qualified sites collaborating with QuintilesIMS to improve the speed, efficiency and quality of clinical research across all phases of development.  Through the agreement signed recently, CCST and QuintilesIMS will strategically collaborate to raise the efficiency and volume of ECD research conducted in New Zealand on behalf of biopharmaceutical and medical device companies. CCST has worked with QuintilesIMS for 15 years; the Prime Site alliance will take that collaboration to the next level.